ArticleACS chemical neuroscience2019

Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.

Samuel Obeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.